Navigation Links
Pfizer’s Eraxis Approved By The FD

Pfizer Inc announced the approval of a new antifungal drug, for the treatment of bloodstream infection by the FDA. The new drug called Eraxis, // is indicated in the treatment of candidemia, a hospital acquired fatal blood infection.

The improved performance of Eraxis compared to Diflucan, a currently employed anti-fungal treatment is said to have supported the approval. The drug can also be used in the treatment of infections caused by Candida (a fungus), intra-abdominal abscesses, fungal infection of the esophagus and peritonitis.

The acquisition of Vicuron Pharmaceuticals Inc. by Pfizer in September is said to have set stage for acquiring Eraxis. The company’s share value in the afternoon fell down to 18% ($25.65) on the New York Stock Exchange.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Pfizer’s Anti-smoking Dru
2. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
3. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
4. New FDA Approved Drug To Treat Migraine
5. New FDA Approved Drug NATRECOR For Heart Failure Patients
6. New Oral Rinse For Gingivitis Approved By FDA
7. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
8. AIDS Generic Drugs Approved by FDA for Sale in US
9. FDA Approved Nerve-Stimulation Therapy Now Available In New York
10. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
11. Inhalers for Kids Was Approved By the FDA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Neil H. Greco ... planning assistance to communities throughout the region, is launching a charity drive to raise ... is by far the deadliest killer in America, and is responsible for 1 in ...
(Date:1/17/2017)... Los Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... today announced the results of a double blind clinical study for its dental gel ... to a leading national brand of toothpaste containing triclosan. The study was conducted at ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... from two offices in Tyler, has announced the latest beneficiary of their thriving ... Network, a nonprofit organization dedicated to fulfilling the dreams of terminally ill patients. ...
(Date:1/17/2017)... ... ... Today, FloSports , a global leader in live digital sports and original ... long-term extension of their media partnership. The partnership, which began in 2013, will now ... events exclusively on FloWrestling.com as well as usage of the FloArena meet management software ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
(Date:1/18/2017)... Jan. 18, 2017  Tarix Orphan LLC today announced ... a Rare Pediatric Disease (RPD) designation for the company,s ... Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. There ... is limited to supportive care. "The RPD ... Designation previously granted by the FDA in this indication," ...
(Date:1/18/2017)...  Robust competition in the private marketplace is resulting in ... to a new study by the Berkeley ... to examine the share of prescription medicine spending retained ... health plans and other stakeholders in the supply chain. ... show what happens when the list price of a ...
Breaking Medicine Technology: